Category Specific RSS

Respiri

Respiri and Echo IQ team up to expand into the US with heart disease detection and remote post-consultation care

AI and medical technology firm Echo IQ Limited (ASX: EIQ) has inked a commercial licensing agreement with respiratory health MedTech…

1 year ago

Digital Human platform building momentum as UNITH signs its most clients in September quarter

As more businesses around the world seek solutions to address unreliable staff and reduce excess payroll expenses, artificial intelligence company…

2 years ago

Respiri hoping asthma sufferers will pay $20 a month for this

Covid made many things worse, including the lives of asthma patients who were more vulnerable to the disease than others.…

3 years ago

Respiri addresses cash burn by targeting cheaper labour in The Philippines

After less than satisfactory ventures in India and the USA, medtech company dedicated to respiratory health Respiri (ASX: RSH) is…

3 years ago

Respiri engages Chinese production to up asthma device manufacturing

Medtech company Respiri (ASX: RSH) has continued its long path towards commercialisation of its asthma diagnostics device 'wheezo', having entered…

5 years ago

Respiri to enter asthma telehealth, wheezo commercialisation looms

Under new management, medtech company Respiri (ASX: RSH) is poised to enter the lucrative SaaS revenue market by leveraging their…

5 years ago